Generation and growth of the blood vasculature network is a highly synchronized process, requiring coordinated efforts of endothelial cells and pericytes to maintain blood vessel integrity and regeneration. In a recent paper published in Cell Research, Yu et al. identified and characterized bipotent Procr-expressing vascular endothelial stem cells, which give rise to both endothelial cells and pericytes.
The vasculature is a complex transport system, composed of a remarkable network of arteries, veins and connecting capillaries of the blood system that supply every organ with oxygen and nutrients. Blood vessels also regulate organ development, regeneration and stem cell behavior. Endothelial stem cells are highly plastic and can rapidly switch from long-term quiescence to active angiogenic growth upon metabolic and stress stimulations. Vascular growth and remodeling are vital for successful organ growth and play a major role in tissue repair. However, this dynamic property also holds dark sides as vascular sprouting provides survival and growth cues to allow tumor progression and metastasis spreading. Identifying the root origin of the vascular segments could potentially make it possible to aid in the development of therapies to promote vascular repair or to prevent blood vessel growth within tumors. During the last decade, much effort has been devoted toward isolating and characterizing the adult stem cells that give rise to the vascular endothelium. A growing body of evidence indicates that tissueresident endothelial stem and progenitor cells are the major source of mature endothelial cells for vascular renewal and repair, over bone marrow-derived endothelial precursors [1] . The report by Yu et al. [2] provides strong evidence to support this concept and identifies protein C receptor-expressing (Procr, also known as endothelial protein C receptor -EPCR) endothelial stem cells as the apex of the bipotent lineage tree for both endothelial cells and pericytes, providing new understanding on the root of adult neovascularization in homeostasis and injury repair.
To identify vascular endothelial stem cells (VESCs), Yu and To the best of our knowledge and understanding, this is the first documentation of an adult bipotent common vascular progenitor that gives rise to both endothelial and periendothelial cells. These results are in line with previous observations revealing a common bipotent embryonic vascular progenitor cell that differentiates into both endothelial and smooth muscle cells [3] .
Procr has been identified as a stem cell marker also in various other tissues including long-term repopulating hematopoietic stem cells (LT-HSCs) in the fetal liver during embryo development [4] and adult bone marrow [5, 6] , and more recently in mammary stem cells [7] . Procr has clear endothelial characteristics, and its ligation with the serine protease, activated protein C (aPC), induces classic PAR1-mediated anticoagulation with anti-apoptotic and anti-inflammatory activities, as well as promotes endothelial barrier protection and stabilization [8] . Current evidence reveals that the aPC/EPCR pathway plays an important role in both fetal hematopoietic stem cell survival [4] and adult LT-HSC retention in the bone marrow and protection from myelotoxic insult [9] . Protection from DNA damaging agents via aPC/EPCR/PAR1 signaling limits nitric oxide generation and Cdc42 activity, leading to enhanced VLA4-mediated adhesion and stem cell retention to ensure preservation of the bone marrow stem cell pool [9] . Preservation of Procr expression among different stem cell types strongly implies that Procr provides common stem cell signals, which may preserve the 'stemness' phenotype ( Figure 1) .
The cancer stem cell paradigm refers to the ability of cancer cell subpopulation to initiate tumorigenesis by undergoing extensive self-renewal and differentiation [10] . It becomes clear that the high frequency of relapse predicts that cancer stem cells are resistant to standard therapy [11] , therefore making strong claim that targeting the stem cell population will likely lead to improved patient outcomes. Procr was identified as a marker not only for healthy mammary stem cell population [7] , but is also highly expressed by a cancer stem celllike populations in aggressive human breast cancer cells [12] . Since cancerinitiating cells are the lineage tree origin for chemotherapy resistance and disease relapse, a better understanding of how a single Procr + stem cell remains dormant within its niches and how it is protected will broaden our knowledge of how to eliminate the hiding cancer stem cell.
In light of these important observations, the study by Yu et al. [2] 
